share_log

Ascendis Pharma A/S | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(6.9%)

Ascendis Pharma A/S | SC 13G:超過5%持股股東披露文件-T. Rowe Price Investment Management, Inc.(6.9%)

美股SEC公告 ·  02/14 14:31
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息